期刊文献+

纤溶酶原激活物抑制物-1基因4G/5G多态性与肺动脉血栓栓塞的关系 被引量:3

Relationship between 4G/5G polymorphism of promotor of plasminogen activator inhibitor-1 gene and pulmonary thromboembolism
原文传递
导出
摘要 目的 探讨纤溶酶原激活物抑制物-1(PAI-1)基因4G/5G多态性与肺动脉血栓栓塞(PTE)的关系.方法 应用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术检测76例PTE患者和74例年健康对照者PAI-1基因多态性分布特征.比较两组基因型、等位基因频率分布,分析其遗传模式并观察各基因型对不同临床亚组的影响.结果 4G/4G基因型频率病例组(50.0%)明显高于对照组(24.3%)(P〈0.01),4G/4G、4G/5G及5G/5G 3种基因型频率PTE组与对照组比较差异有统计学意义;4G等位基因频率病例组(72.4%)高于对照组(55.4%),4G和5G等位基因频率PTE组与对照组比较差异有统计学意义.与5G/5G及4G/5G基因型相比,4G/4G基因型显著增加个体肺栓塞危险(OR=3.40,P〈0.01).无明确环境诱因组4G/4G基因型频率显著高于对照组(P=0.04),而有环境诱因组与对照组比较4G/4G基因型频率差异无统计学意义.结论 PAI-1基因多态性与肺栓塞有关,4G等位基因是隐性作用方式,4G/4G基因型显著增加无环境诱因个体肺栓塞危险. Objective To investigate the relationship between 4G/5G polymorphism in the promotor of plasminogen activator inhibitor-1 (PAI-1) gene and pulmonary thromboembolism (PTE). And to detect whether it plays an important role in the pathogenesis of PTE. Methods The 76 patients with PTE, 74 gender and age matched healthy controls were recruited in this study. Genome DNA was extracted from whole blood using phenol-chloroform. Subjects were genotyped for the 4G/ 5G polymorphism of PAI-1 gene using polymerase chain reaction and restriction fragment length polymorphism analysis. Results Significant difference was found in the frequency of 4G/4G genotype between PTE group and control group (50.0% vs.24.3%,P〈0.01). And there were no significant differences in 4G/5G and 5G/5G genotype between the two groups. The 4G allele frequency was higher in PTE group than in control group (72.4% vs. 55.4% , P〈0.01) . The recessive allele model was informative and the odd ratio of 4G/4G genotype was much higher than of other two genotypes (OR=3.40, P〈0.01). Further stratification showed 4G/4G genotype was associated with high risk of PTE for those individuals without traditional environment risk factors. Conclusions The 4G/5G polymorphism of PAI-1 gene is associated with PTE and 4G allele is recessive. 4G/4G genotype increases the risk of PTE for individuals who have no traditional risk factors of PTE.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2010年第7期555-558,共4页 Chinese Journal of Geriatrics
基金 国家重点科技项目计划子专题(96920-06-05-1) 北京市卫生局首都医学发展科研基金(zd199912)
关键词 纤溶酶原激活物抑制物1 基因表达 肺栓塞 Plasinogen activator inhibitor-1 Gene expression Pulmonary embolism
  • 相关文献

参考文献12

  • 1European Society of Cardiology.Guideline on diagnosis and management of acute pulmonary embolism.Eur Heart J,2000,21:1301-1336.
  • 2Lang IM,Marsh JJ,Olman MA,et al.Parallel analysis of tmsue-type plasminogen activator and type l plasminogen activator inhibitor in plasma and endothelial cells derived from patients with chronic pulmonary thromboemboli,Circulation,2004,90:706-712.
  • 3Rosenhek R,Korschineck I,Gharehbaghi-Sehnell E,et al.Fibrinolytic balance of the arterial wall:pulmonary artery displays increased fibrinolytic potential compared with aorta.Nature,2003,83:871-876.
  • 4Siren V,Kauhanen P,Carpen O,et al.Urokinase,tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in severely stenosed and occluded vein grafts with thrombosis.Blood Coagulation and Fibrinolysis,2003,14:369-377.
  • 5张爱元,季祥武,管立学,黄静,张爱娟,王敬先.PAI-1基因多态性与冠状动脉粥样硬化性心脏病患者预后的相关性研究[J].中华医学遗传学杂志,2008,25(2):233-235. 被引量:3
  • 6张晨,李江,李玲,罗兵.PAI-1启动子区插入/缺失(5G/4G)多态性与脑血管病的相关性研究[J].中华医学遗传学杂志,2001,18(5):383-387. 被引量:18
  • 7翟振国,王辰,杨媛华,庞宝森,肖白,刘艳梅,毛燕玲,翁心植.纤溶酶原激活物抑制剂-1启动子区域基因多态性与肺血栓栓塞症的相关性研究[J].中华医学杂志,2006,86(19):1313-1317. 被引量:13
  • 8Zoller B,Garcia de Frutos P,Dahlback B.A common 4G allele in the promoter of the plasminogen activator inhibitor-1(PAI-1)gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary proteins deficiency.Thromb Haemost,1998,79:802-807.
  • 9Segui R.Estelles A.Mira Y,et al.PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects.Br J Haematol,2000,111:122-128.
  • 10胡云建,陶凤荣,王厚东,张秀珍,赵丽,朱震宏.D-二聚体测定在肺栓塞诊断中的应用价值[J].中华检验医学杂志,2002,25(2):95-97. 被引量:142

二级参考文献17

  • 1Francis CW.Plasminogen activator inhibitor-1 levels and polymorphisms.Arch Pathol Lab Med,2002,126:1401-1404.
  • 2Iwai DA,Shimoike H,Nakamura Y,et al.The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes.Atherosclerosis,1998,136:109-114.
  • 3Xiao W,Oefner PJ.Denaturing high-performance liquid chromatography:a review.Hum Mutat,2001,17:439-474.
  • 4Nilsson IM,Ljungner H,Tengborn L.Two different mechanisms in patients with venous thrombosis and defective fibrinolysis:low concentration of plasminogen activator increased concentration of plasminogen activator inhibitor.BMJ,1985,290:1453-1456.
  • 5Dawson S,Hamsten A,Wiman B,et al.Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasminogen activator inhibitor-1 activity.Arterioscler Thromb,1991,11:183-190.
  • 6Ericksson P,Kallin B,van't Hooft FM,et al.Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.Proc Natl Acad Sci USA,1995,92:1851.
  • 7Grubic N,Stegnar M,Peternel P,et al.A novel G/A and the 4G/5G polymorphism within the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosis.Thromb Res,1996,84:431-443.
  • 8Sartori MT,Wiman B,Vettore S,et al.4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.Thromb Haemost,1998,80:956-960.
  • 9Ridker PM,Hennekens CH,Lindpaintner K,et al.Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men.Circulation,1997,95:59-62.
  • 10Akar N,Yilmaz E,Akar E,et al.Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV1691 G-A.Thromb Res,2000,97:227 -230.

共引文献170

同被引文献16

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部